Get With the Guidelines Atrial Fibrillation Registry (GWTG-AF)

January 27, 2025 updated by: American Heart Association

Get With the Guidelines-Atrial Fibrillation

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Get With The Guidelines-Atrial Fibrillation was initiated in 2013 with over 88 U.S. hospitals participating is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Achievement measures tracked through Get With The Guidelines-Atrial Fibrillation:

  1. ACEI/ARB at discharge for LVSD
  2. Assessment of thromboembolic risk factors
  3. Beta Blocker at discharge
  4. Discharged on FDA-approved anticoagulation therapy
  5. PT/INR planned follow-up
  6. Statin at discharge in AF patients with CAD, CVA/TIA or PVD.

Quality measures tracked through Get With The Guidelines-Atrial Fibrillation:

  1. Aldosterone antagonist at discharge
  2. Atrial fibrillation patient education
  3. Anticoagulation therapy education
  4. CHA2DS2-VASC reported
  5. Discharge heart rate <110bpm
  6. Smoking cessation
  7. Warfarin at discharge for valvular atrial fibrillation

Additional measures collected by Get With The Guidelines-Atrial Fibrillation can be viewed at: http://www.heart.org/idc/groups/heart-public/@private/@wcm/@hcm/@gwtg/documents/downloadable/ucm_451183.pdf

Study Type

Observational

Enrollment (Estimated)

17198

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

The study population is patients with the diagnosis of nonvalvular Atrial Fibrillation or Atrial Flutter.

Description

Inclusion Criteria:

  • Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter

Exclusion Criteria:

  • Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter
  • Patients under 18 years of age
  • Patients not admitted as inpatients.
  • Patients on comfort care only
  • Patients discharged to hospice.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiac Tamponade and/or Pericardiocentesis Following Ablation
Time Frame: 30 days
Percent of patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days following ablation procedure.
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

American Heart Association

Investigators

  • Principal Investigator: Javed Butler, MD, American Heart Association

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Estimated)

January 1, 2040

Study Completion (Estimated)

January 1, 2040

Study Registration Dates

First Submitted

February 23, 2016

First Submitted That Met QC Criteria

January 29, 2024

First Posted (Actual)

February 7, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 27, 2025

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 002 (University of CT Health Center)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Atrial Fibrillation

Clinical Trials on GWTG Atrial Fibrillation program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe